CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery
Kheirolomoom, Azadeh | Ingham, Elizabeth S. | Mahakian, Lisa M. | Tam, Sarah M. | Silvestrini, Matthew T. | Tumbale, Spencer K. | Foiret, Josquin | Hubbard, Neil E. | Borowsky, Alexander D. | Murphy, William J. | Ferrara, Katherine W.
Ultrasonic activation of nanoparticles provides the opportunity to deliver a large fraction of the injected dose to insonified tumors and produce a complete local response. Here, we evaluate whether the local and systemic response to chemotherapy can be enhanced by combining such a therapy with locally-administered CpG as an immune adjuvant. In order to create stable, activatable particles, a complex between copper and doxorubicin (CuDox) was created within temperature-sensitive liposomes. Whereas insonation of the CuDox liposomes alone has been shown to produce a complete response in murine breast cancer after 8 treatments of 6mg/kg delivered over 4weeks, combining this treatment with CpG resolved local cancers within 3 treatments delivered over 7days. Further, contralateral tumors regressed as a result of the combined treatment, and survival was extended in systemic disease. In both the treated and contralateral tumor site, the combined treatment increased leukocytes and CD4+ and CD8+ T-effector cells and reduced myeloid-derived suppressor cells (MDSCs). Taken together, the results suggest that this combinatorial treatment significantly enhances the systemic efficacy of locally-activated nanotherapy.Show more [+] Less [-]